This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (July 2021)
|
Konstantinos Drosatos
| |
---|---|
![]() | |
Born |
Athens, Greece
|
Nationality | Greek |
Citizenship | Greek & USA |
Education |
|
Alma mater | Aristotle University of Thessaloniki |
Scientific career | |
Institutions | |
Thesis | Gene regulation and functions of Apolipoprotein E (2007) |
Website | www |
Konstantinos Drosatos (Greek: Κωνσταντίνος Δροσάτος), born in Athens, Greece, is a Greek-American molecular biologist, who is the Ohio Eminent Scholar and Professor of Pharmacology and Systems Physiology at the University of Cincinnati College of Medicine in Cincinnati, Ohio, U.S. His parents were Georgios Drosatos and Sofia Drosatou; his family originates in Partheni, Euboea, Greece.[1]
Drosatos received his B.Sc. from the department of biology at the Aristotle University of Thessaloniki, Greece in 2000. In 2000, he continued with graduate studies at the Molecular Biology-Biomedicine graduate program of the department of biology and the medical school of the University of Crete. He received his M.Sc. in 2002 and his Ph.D. in molecular biology-biomedicine in 2007. During his graduate studies (2002–2007) he was a visiting research scholar in the laboratory of Vassilis I. Zannis[2] at Boston University Medical School. Following his graduation with a PhD in molecular biology-biomedicine in 2007, he joined the laboratory of Ira J. Goldberg at Columbia University, where he pursued post-doctoral training until 2012,[3] when he was promoted to associate research scientist in the department of medicine at Columbia University. In 2014 he joined the faculty of the Lewis Katz School of Medicine at Temple University as an assistant professor in pharmacology and in 2020, he was promoted to associate professor with tenure in cardiovascular sciences (primary affiliation). In 2022, he was recruited at the University of Cincinnati College of Medicine, which he joined as the Ohio Eminent Scholar and Professor of Pharmacology and Systems Physiology [4]
The research in his laboratory focuses on cardiovascular and systemic metabolism and particularly on signaling mechanisms that link cardiac stress in diabetes, sepsis and ischemia with altered myocardial fatty acid metabolism. His published work focuses on the transcriptional regulation of proteins that underlie lipoprotein metabolism, cardiac and systemic fatty acid metabolism, and mitochondrial function. His work has identified the role of Krüppel-like factor 5 (KLF5) in the regulation of cardiac fatty acid metabolism in diabetes[5][6] and ischemic heart failure,[7] as well as how cardiac lipotoxicity leads to cardiac dysfunction,[8][9] and the importance of cardiac fatty acid oxidation and mitochondrial integrity for the treatment of cardiac dysfunction in sepsis.[10][11][12]
Authority control databases: Academics ![]() |
|
---|